An international team of musculoskeletal oncology experts have explored several important questions regarding the surgical treatment of patients through secondary analyses of data from the
Month: July 2023
The new JBJS Guest Editorial “What’s New in Musculoskeletal Infection” presents findings related to chronic periprosthetic joint infection, oral antibiotic prophylaxis, and more. Here, we
A new study evaluates sociodemographic factors impacting racial and ethnic disparities in baseline PROM scores of foot and ankle patients. JBJS Editor-in-Chief Dr. Marc Swiontkowski
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their outstanding efforts. All JBJS reviewers
Journal clubs that received JBJS funding support in October 2022 had much to say about their year of meetings. Here are a few updates from